Computational Toxicology

Chapter 13Open Science Data Repository for Toxicology

Valery Tkachenko¹, Richard Zakharov² and Sean Ekins³

¹Rockville, MD, USA

²Rockville, MD, USA

³Collaborations Pharmaceuticals, Inc., Raleigh, NC, USA

Chapter Menu

1. Introduction
2. Open Science Data Repository
3. Benefits of OSDR
4. Technical Details
5. Future Work

13.1 Introduction

Tools for collaboration predominantly revolve around desktop computer applications [1, 2] and use “software as a service” as a business model [1–3]. These desktop software have also become more widely accessible in academia and small companies (e.g., CDD Vault, Science Cloud). Such applications are useful for secure sharing of data with collaborators in which retention of intellectual property (IP) is important. However, we are increasingly seeing a shift to more companies, institutes, and researchers openly sharing data, regardless of IP. While this has been predominantly in the neglected disease space (GlaxoSmithKline, Novartis, and St. Jude's sharing malaria and tuberculosis data) [4–8] this is starting to broaden, for example, GlaxoSmithKline sharing of kinase data [9] and AstraZeneca sharing their Absorption, Distribution, Metabolism and Excretion (ADME) data on ChEMBL [10]. Alongside this, there are increasing efforts from researchers to publish in open access journals and release data into open or free databases [11, 12]. In addition, there are an increasing number of online tools that are viable for storing science-related content, for example, FigShare ...